These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1832980)

  • 1. Mesangial cell immune injury: effects of thromboxane receptor antagonism.
    Bresnahan BA; Roman RJ; Bagchus WM; Lianos EA
    J Am Soc Nephrol; 1991 Feb; 1(8):1041-7. PubMed ID: 1832980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiologic role of eicosanoids in mesangial cell immune injury.
    Lianos EA; Bresnahan BB; Wu S
    J Lipid Mediat; 1993; 6(1-3):333-42. PubMed ID: 8357992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.
    Bresnahan BA; Wu S; Fenoy FJ; Roman RJ; Lianos EA
    J Clin Invest; 1992 Dec; 90(6):2304-12. PubMed ID: 1361493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL; Darius H; Lefer AM
    Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids.
    Lianos EA; Bresnahan BA; Pan C
    J Clin Invest; 1991 Aug; 88(2):623-31. PubMed ID: 1677947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
    Lianos EA; Bresnahan BA
    J Lab Clin Med; 1999 Nov; 134(5):478-82. PubMed ID: 10560941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
    Grover GJ; Schumacher WA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosanoid-induced growth and signaling events in rat glomerular mesangial cells.
    Kelefiotis D; Bresnahan BA; Stratidakis I; Lianos EA
    Prostaglandins; 1995 May; 49(5):269-83. PubMed ID: 7659782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of glomerular thromboxane receptor sites in the rat.
    Wilkes BM; Solomon J; Maita M; Mento PF
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1111-6. PubMed ID: 2525345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal vasoconstriction with U-46,619; role of arachidonate metabolites.
    Wilcox CS; Folger WH; Welch WJ
    J Am Soc Nephrol; 1994 Oct; 5(4):1120-4. PubMed ID: 7849252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
    Miki I; Kishibayashi N; Nonaka H; Ohshima E; Takami H; Obase H; Ishii A
    Jpn J Pharmacol; 1992 Jul; 59(3):357-64. PubMed ID: 1434130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells.
    Coffman TM; Spurney RF; Mannon RB; Levenson R
    Am J Physiol; 1998 Aug; 275(2):F262-9. PubMed ID: 9691017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
    Grover GJ; Schumacher WA
    Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice.
    Darius H; Lefer AM
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):364-8. PubMed ID: 2996012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
    Mistry M; Nasjletti A
    Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
    Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
    J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
    Welch WJ; Wilcox CS; Dunbar KR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.